Polymorphism, alcohol and alcoholic liver disease

I. Roberts‐Thomson,WJ Butler

DOI: https://doi.org/10.1111/j.1440-1746.2004.03734.x

2004-12-01

Journal of Gastroenterology and Hepatology

Abstract:Why do only a minority of alcoholics, perhaps 10%, develop serious liver disorders such as cirrhosis and alcoholic hepatitis? Obvious possibilities include variation in total alcohol intake, patterns of alcohol abuse and diet. Indeed, minor increases in risk have been reported for higher intakes of alcohol, daily versus binge drinking and diets low in micronutrients such as copper, zinc and selenium. Obesity is also a risk factor for the development of liver disease in heavy drinkers but this is more striking for steatosis than for cirrhosis. The possibility that genetic factors might influence susceptibility to both alcoholism and alcoholic liver disease is supported by twin and family studies. Polymorphisms of potential relevance to alcoholism were summarized in the November issue of the Journal. In relation to liver disease, a study in male veterans showed that concordance rates for cirrhosis in monozygotic twins were threefold higher than those in dizygotic twins. This has led to a search for genetic variation (polymorphism) that might promote either hepatic inflammation or fibrosis. These processes are complex but could include oxidative stress, cytokine activity, immune responsiveness or fatty acid metabolism. Polymorphisms that have been reported to be associated with advanced alcoholic liver disease are summarized in Table 1. One mechanism for the generation of reactive oxygen species (oxidative stress) involves the activity of the cytochrome P450 enzyme, CYP2E1. A mutation in the promoter region (c2 allele) results in enhanced enzyme activity and appears to be associated with some increase in risk for cirrhosis in both Japanese and Caucasian populations. Excessive liver iron might also promote oxidative stress but Caucasian patients with alcoholic liver disease do not have a higher than expected frequency of alleles (C282Y and H63D) associated with hemochromatosis. In relation to cytokines, hepatic inflammation might be promoted by an excess of pro-inflammatory cytokines or by a deficiency of anti-inflammatory cytokines. One polymorphism of interest involves the antiinflammatory cytokine interleukin-10 (IL-10). In one study, a mutation in the IL-10 promoter (C-627 A) that suppresses gene transcription was more frequent in heavy drinkers with advanced liver disease than in heavy drinkers with milder liver disease or in healthy controls. An association has also been reported between advanced liver disease and an uncommon polymorphism (G-238 A) in the pro-inflammatory cytokine, tumor necrosis factor-alpha (TNF-a) that appears to enhance expression of TNF-a. Other candidate polymorphisms include interleukin-1 beta (IL-1b), CD14, manganese superoxide dismutase (MnSOD) and an immunoregulatory molecule called cytotoxic T lymphocyte antigen-4